The drugmaker said its product is indicated for the treatment of patients with acromegaly and gastroenteropancreatic ...

The approval includes multiple strengths of Lanreotide injection, a therapeutic equivalent generic version of Somatuline Depot Injection.

Cipla's Lanreotide injection is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic ...

Although the medical condition acromegaly may be fairly rare, for those who do live with the hormone disorder, it can cause a ...

US drug regulators have turned down Ipsen's effort to slow down generic competition for its blockbuster drug Somatuline Depot ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions ...

Drug major Cipla on Wednesday said it has received approval from the US health regulator to market a generic medication used ...

Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the ...

The wholly-owned subsidiary Cipla USA Inc has received the final approval for the Abbreviated New Drug Application (ANDA) of ...

Q1 2024 Earnings Call Transcript May 11, 2024 Crinetics Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among ...

Mumbai-headquartered pharma major, Cipla's US arm has secured final approval from the United States Food and Drug ...

Crinetics just released initial data from its phase 2 open-label study using its drug Atumelnant. Read why I'm bullish on ...